FierceBiotechOriginal article
{"a":[{"_":"Arpeggio plays final chord as biotech disbands on poor prospects for Nrf2 program","$":{"href":"/biotech/arpeggio-plays-final-chord-biotech-disbands-poor-prospects-nrf2-program","hreflang":"en"}}]}
Negative
AI Analysis
Summary
Arpeggio Biosciences is disbanding after eight years of operation due to poor prospects for its Nrf2 program, with the CEO acknowledging the program had started to unravel.
Outcome Details
Company disbanding due to poor prospects for Nrf2 program
Importance:4/10
Sentiment:
-0.90
company dissolutionpipeline failureNrf2transcriptome
Read the original article
Published by FierceBiotech on August 10, 2026 5:06 AM